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ABSTRACT
Introduction Women comprise two- thirds of people with 
dementia, making female sex a significant dementia risk 
factor. Both type 1 diabetes (T1D) and type 2 diabetes 
(T2D) are known dementia risk factors with an increasing 
global incidence. Understanding whether subtle sex 
differences persist in cognitive function prior to dementia 
in the context of diabetes may help elucidate the 
magnitude of sex effects on dementia risk.
Research design and methods We examined cross- 
sectional data from the Study of Longevity in Diabetes 
(SOLID), a prospective cohort study of members of 
Kaiser Permanente Northern California aged 60 years 
and older with T1D (n=758), T2D (n=232) and without 
either T1D or T2D (n=247). We used factor analysis to 
generate summary scores of cognitive domains and used 
regression analyses to examine the associations between 
sex and cognition adjusting for sociodemographic and 
cardiovascular confounders.
Results We included 1237 participants (630 women 
and 607 men) with mean age 68 years. By design, 
the distribution of men and women in T1D, T2D and 
no diabetes was similar. Women had better cognitive 
performance than men in global cognition (β=0.21, 
95% CI 0.16 to 0.26), language (β=0.08, 95% CI 0.004 to 
0.15), executive function (β=0.13, 95% CI 0.05 to 0.20), 
episodic verbal memory (β=0.68, 95% CI 0.59 to 0.77) and 
attention (β=0.20, 95% CI 0.11 to 0.28) but not in episodic 
visual memory (β=0.006, 95% CI −0.07 to 0.09) adjusting 
for age and education independent of diabetes status. We 
did not find an interaction between sex and diabetes status 
for any of the cognitive outcomes.
Conclusions Women in late mid- life have better cognitive 
performance than men in many cognitive domains 
independent of the presence of T1D or T2D. Further work 
is required to understand whether these differences 
change over time or in older cohorts and to understand 
their relationship to subsequent dementia.
INTRODUCTION
Female sex is a risk factor for dementia.1 
Women make up approximately half the 
world population,2 yet two- thirds of people 
with dementia are women. This makes the 
disproportionate burden of dementia in 
women a large public health concern. The 
reasons for this increased risk in women are 
unclear but previous work suggest that there 
may be sex- specific etiological factors in addi-
tion to simply increased longevity.3 The global 
incidence of both type 1 diabetes (T1D) and 
type 2 diabetes (T2D) is increasing4 and, 
depending on the population studied, there 
also appears to be sex differences in diabetes 
incidence.5 Recently, both T1D and T2D have 
been shown to be associated with an increased 
risk of dementia.6 7 However, whether the 
known sex differences in dementia risk 
extend to those with diabetes or is altered 
by diabetes is poorly understood.8 There are 
sex- related differences in the incidence of 
diabetes complications,9–11 yet, it is unknown 
whether there are also sex differences in 
cognitive function related to diabetes.
Significance of this study
What is already known about this subject?
 ► Both female sex and diabetes are risk factors for de-
mentia, but the underlying mechanisms are unclear.
 ► It is not known whether the previously described sex 
differences in cognitive function differ depending on 
whether a person has type 1, type 2 or no diabetes.
What are the new findings?
 ► In a study of 1237 people (mean age 68 years), we 
found that women had better cognitive performance 
than men in a number of cognitive domains includ-
ing global cognition, language, executive function, 
attention and verbal memory.
 ► Women and men had similar visual memory scores.
 ► The sex differences in cognition did not vary by the 
presence or absence of diabetes or whether a per-
son had type 1 or type 2 diabetes.
How might these results change the focus of 
research or clinical practice?
 ► Our results demonstrate the presence of sex dif-
ferences in cognition across diabetes states and 
encourage further research to better understand 
whether the differences we report change over time 
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Clarifying whether sex differences persist in cognitive 
function in the context of diabetes helps elucidate the 
magnitude of sex effects on dementia risk.
Neuropsychological testing in people without dementia 
allows the detection of subtle cognitive changes that may 
precede the development of dementia. This allows the 
potential to identify important mechanisms and risk 
factors prior to the development of overt functional 
impairment. For example, when compared with men, 
women tend to perform more poorly in some cognitive 
tasks and better in others.12 13 The reasons underlying 
these sex differences are unknown but may be related 
to the neuronal activity of sex hormones.13–15 Greater 
understanding of the factors associated with increased 
dementia risk is essential to the targeting of interventions 
to high- risk groups such as women. We evaluated whether 
the associations of sex and cognitive function in mid- 
later life differs by diabetes status in a group of people 
without dementia. Our hypothesis was that women would 
perform more poorly in the cognitive tests than men and 
these would differ by diabetes status.
RESEARCH DESIGN AND METHODS
Study population
The Study of Longevity in Diabetes (SOLID) is a prospec-
tive cohort study of aging and diabetes that recruited 
members of Kaiser Permanente Northern California 
(KPNC) aged 60 years and older with T1D, T2D and 
without either T1D or T2D. Details of participant eligi-
bility and inclusion have been published previously and 
briefly presented in online supplemental figure 1.16–18 
Potential participants with T1D were identified in elec-
tronic medical records using International Classification 
of Diseases (ICD)-9 and ICD-10 codes for T1D (250.x1, 
250.x3 or E10.x) or T2D (250.x0, 250.x2, E11.x). As per 
previous work using the SOLID dataset,16–18 individuals 
with diagnostic codes related to both types of diabetes 
were classified as having T1D if at least 75% of diag-
nostic codes related to diabetes were for T1D specifically 
and the member was prescribed insulin to reduce the 
risk of misclassification. Enrolled participants with T1D 
were then used to guide recruitment of two comparator 
groups: people with T2D and people without either T1D 
or T2D. Individuals with T1D were population frequency 
matched to potential participants with T2D or without 
either T1D or T2D. Individuals with diagnostic codes 
related to both types of diabetes were classified as having 
T2D if at least 75% of diagnostic codes related to diabetes 
were for T2D. Population distribution matching was 
performed on the following factors: sex, age (grouped 
as: 60–64, 65–69, 70–74, 75–79, 80–84, 85–89, 90+ years), 
race/ethnicity and education.
Participants completed a number of items regarding 
demographic, general health, diabetes complications, 
health literacy (Rapid Estimate of Adult Literacy in 
Medicine- Short Form,19 mood (Geriatric Depression 
Scale (GDS)) and sleep quality (a modified version of 
the Pittsburg Sleep Quality Index (PSQI)).20 Presence of 
microvascular (retinopathy, neuropathy, nephropathy) 
and macrovascular disease (stroke, myocardial infarc-
tion) at baseline were captured through self- report of a 
physician’s diagnosis at baseline. A comprehensive cogni-
tive battery, described below, was then administered by 
trained interviewers.
Cognitive function
We conducted factor analysis on the cognitive assess-
ments of all participants and identified five cogni-
tive domains: language, executive function, episodic 
verbal memory, episodic visual memory and simple 
attention. The language domain was comprised of the 
phonemic fluency test (F and L), the category fluency 
test (animals and vegetables), list sorting (two alter-
native lists) and Multilingual Naming Test. The exec-
utive function domain comprised the Trail Making 
Test (A and B), the Digit Symbol Substitution Test and 
the Stroop Color and Word Tests. The episodic verbal 
memory domain consisted of the Word List Learning 
Test (immediate and delayed). The episodic visual 
memory domain consisted of the Word List Learning 
Test (immediate and delayed) and the Benson Complex 
Figure Copy (immediate and delayed). The simple 
attention domain was composed of the Diamond and 
TMX cancellation tests. Each test score was converted 
to a z- score (mean=0; SD=1). For each domain, a 
summary score was calculated by summing the z- scores 
for individuals who completed at least 50% of the rele-
vant tests. A global cognition score was calculated as the 
average of the five domain- specific summary scores for 
individuals who competed at least 50% of all cognitive 
function tests.
Covariables
Age was calculated from date of baseline interview and 
date of birth. Diabetes duration was calculated using 
self- reported age of diabetes onset. Race/ethnicity 
(white, Hispanic, Asian, African- American and other), 
educational attainment, presence of microvascular 
and macrovascular disease (retinopathy, neurop-
athy, nephropathy, stroke, myocardial infarction) and 
diabetes complications (lifetime exposure of severe 
hypoglycemia requiring hospital care and lifetime 
exposure to diabetic ketoacidosis (DKA)) were based 
on self- report. We categorized educational attainment 
as: ‘college degree or greater’ or ‘less than a college 
degree’.
Analytic sample
Of the 1311 individuals enrolled in SOLID (805 indi-
viduals with T1D, 248 individuals with T2D, 258 individ-
uals without diabetes), we excluded 4 participants with 
missing information on educational attainment and 
70 participants who were missing the global cognition 
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Statistical analyses
We examined the distribution of baseline characteristics 
in the overall sample, then by sex and by diabetes status. 
Within each of the categories of no diabetes, T1D and 
T2D, we examined mean standardized scores on global 
and domain- specific cognitive measures without covariate 
adjustment. For our main analysis, we specified linear 
regression models to examine the association between 
sex (using men as reference) and performance on global 
and domain- specific measures of cognition. First, we 
performed these models in the whole group, including 
diabetes status as a covariate. We then specified linear 
regression models of the associations between sex and the 
cognitive outcomes among individuals with no diabetes, 
T1D and T2D separately. Literature research and knowl-
edge of previously published associations found in this 
sample guided our identification of covariates. In each of 
these models, we initially fitted base models that adjusted 
for age and education. We then added diabetes status, 
race/ethnicity, PSQI and GDS score in a stepwise fashion 
to explore how these factors, that have been shown to 
be associated with cognition in this sample,17 18 influ-
enced any sex- cognitive performance relationship. We 
then tested a final model including health literacy and 
cardiovascular health measures (neuropathy, nephrop-
athy, retinopathy, stroke and myocardial infarction). 
We also explored whether the relationship between 
age (adjusting for sex and education) and the cognitive 
scores was linear or quadratic using an Akaike Informa-
tion Criterion (AIC) measure of model fit.
In the models using whole group data, we additionally 
included a product term sex×diabetes status to test for 
a potential interaction (effect modification) between 
sex and diabetes status on cognitive function. We also 
plotted the estimates of these models to visually inspect 
for the possibility of an interaction. We further strati-
fied the final model (including all potentially relevant 
covariables) by diabetes status to explore within- strata 
sex- cognition relationships. In the T1D and T2D groups 
(separately), we additionally examined the effect of 
including lifetime history of DKA and/or severe hypogly-
cemia on sex- cognition model associations. All analyses 
were performed using SAS V.9.4.
RESULTS
Sample characteristics
Of the initial 1311 people recruited into the study, a 
total of 1237 participants (630 women and 607 men) 
had sufficient data to be included in the current study. 
The sample characteristics of those who completed and 
did not complete all cognitive tests (n=70) are presented 
in online supplemental table 1. Broadly, those who did 
not complete all cognitive tests were older, less likely to 
hold a college degree, had lower household income, 
were diagnosed with diabetes at a younger age, had 
longer disease duration and were more likely to report a 
history of severe hypoglycemia and DKA than those who 
completed all cognitive tests. Table 1 describes the char-
acteristics of study participants in the whole group and 
stratified by sex.
The mean age of men and women in all groups were 
similar (~68 years). Approximately 85% of the sample 
were of white ethnicity. Compared with men, women 
were less likely to have completed a college or higher 
degree (58% vs 64%, p=0.03) and reported lower house-
hold income (p<0.0001), lower alcohol use (p=0.04) and 
worse sleep quality (mean PSQI=8.5 vs mean PSQI=7.6; 
p<0.0001). Women had higher GDS scores than men 
(2.2 vs 1.8 p=0.003). By design, the distribution of men 
and women was similar in those with T1D, T2D and no 
diabetes (~50%). Table 2 describes the characteristics of 
study participants stratified by sex and diabetes status. 
The mean age of diabetes diagnosis was approximately 28 
years in those with T1D and was approximately 55 years 
in those with T2D. In those with T1D, men had a little 
longer duration of diabetes (40.4 years, SD=13.9) than 
women (38.0 years, SD=16.0). A similar pattern was seen 
in those with T2D, but this difference was not statistically 
significant (men: 14.5 years; women: 13.5 years). Partic-
ipants with T1D reported higher rates of microvascular 
and macrovascular complications, severe hypoglycemia 
and DKA than those with T2D or with diabetes. However, 
these rates were similar between men and women except 
for lifetime exposure to DKA which was more commonly 
reported by women (35%) than men (21%) (p<0.0001).
Associations between sex and cognitive outcomes
Table 3 presents the associations between female sex and 
the different cognitive domains across the whole group 
and stratified by diabetes status.
We used a linear term for age as it resulted in a slightly 
better model fit than a quadratic term (AIC 1548.5 vs 
1551.3). In the whole group, women had better cogni-
tive performance than men in global cognition (β=0.21, 
95% CI 0.16 to 0.26), language (β=0.08, 95% CI 0.004 to 
0.15), executive function (β=0.13, 95% CI 0.05 to 0.20), 
episodic verbal memory (β=0.68, 95% CI 0.59 to 0.77) 
and attention (β=0.20, 95% CI 0.11 to 0.28) (all p<0.01) 
but not in episodic visual memory (β=0.006, 95% CI −0.07 
to 0.09) adjusting for age and education. The stepwise 
inclusion of diabetes status, race/ethnicity, PSQI and 
GDS score did not meaningfully change these associa-
tions (maximum β change=25%). We did not find a statis-
tically significant sex×diabetes status interaction for any 
of the cognitive outcomes in any of the adjusted models. 
The inclusion of measures of cardiovascular health and 
health literacy resulted in an attenuation of the associ-
ations between female sex and the cognitive outcomes 
with the previously described association between female 
sex and greater performance in language no longer 
statistically significant (β=0.05, 95% CI −0.03 to 0.12).
In exploratory sensitivity analysis, we examined the 
associations between sex and cognition adjusting for age, 
education, race, PSQI and GDS stratified by diabetes 


















are: first published as 10.1136/bm




4 BMJ Open Diab Res Care 2021;9:e001646. doi:10.1136/bmjdrc-2020-001646
Epidemiology/Health services research
Table 1 Sample characteristics stratified by sex
Whole group Women Men P value
n (%) 1237 630 (51) 607 (49)
Demographics
  Age (years), mean (SD) 67.8 (6.6) 67.6 (6.5) 68.0 (6.7) 0.23
  Race/Ethnicity, n (%)
   White 1052 (85) 533 (85) 519 (86)
   Hispanic 97 (8) 59 (9) 38 (6)
   Asian 20 (2) 10 (2) 10 (2)
   African- American 21 (2) 10 (2) 11 (2)
   Other 47 (4) 18 (3) 29 (5) 0.22
  College degree, n (%) 755 (61) 366 (58) 389 (64) 0.03
  Annual household income (US$)
   0–59 999 364 (29) 214 (36) 150 (26)
   60 000–99 000 364 (29) 192 (32) 172 (30)
   100 000–199 000 342 (28) 151 (26) 191 (34)
   >200 000 89 (7) 35 (6) 54 (10) <0.0001
  Health literacy, n (%)
   3rd grade or below 1 (0) 1 (0) 0 (0)
   4th–6th grade 7 (1) 2 (0) 5 (1)
   7th–8th grade 86 (7) 27 (4) 59 (10)
   High school 1143 (92) 600 (95) 543 (89) 0.001
General health
  Every smoked >100 cigarettes, n (%) 538 (43) 262 (42) 276 (46) 0.19
  How often drink alcohol
   Do not drink, n (%) 322 (26) 165 (26) 157 (26)
   At least monthly, n (%) 421 (34) 234 (37) 187 (31)
   At least weekly, n (%) 481 (39) 226 (36) 255 (43) 0.04
  PSQI, mean (SD) 8.0 (2.7) 8.5 (2.8) 7.6 (2.6) <0.0001
  GDS, mean (SD) 2.0 (2.3) 2.2 (2.4) 1.8 (2.1) 0.003
  No diabetes, n (%) 247 (20) 127 (20) 120 (20)
  Type 1 diabetes, n (%) 758 (61) 385 (61) 373 (61)
  Type 2 diabetes, n (%) 232 (19) 118 (19) 114 (19) 0.99
Diabetes characteristics
  Mean age at diabetes onset (years) (SD) 34.4 (18.4) 35.1 (19.0) 33.7 (17.9) 0.23
  Mean diabetes duration (years) (SD) 33.1 (17.8) 32.2 (18.0) 34.1 (17.5) 0.09
  Retinopathy, n (%) 341 (28) 183 (31) 158 (28) 0.30
  Neuropathy, n (%) 374 (30) 191 (31) 183 (32) 0.98
  Nephropathy, n (%) 61 (5) 29 (5) 32 (6) 0.49
  Stroke, n (%) 100 (8) 45 (7) 55 (9) 0.19
  Myocardial infarction, n (%) 126 (10) 54 (9) 72 (12) 0.05
  Severe hypoglycemia n (%) 376 (30) 183 (29) 193 (32) 0.29
  Diabetic ketoacidosis, n (%) 213 (17) 134 (21) 79 (13) 0.0006
Bold signifies p values≤0.05.
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performance in global cognition (β=0.25, 95% CI 0.18 
to 0.31), language (β=0.09, 95% CI −0.002 to 0.19), exec-
utive function (β=0.15, 95% CI 0.05 to 0.25), episodic 
verbal memory (β=0.70, 95% CI 0.58 to 0.83) and atten-
tion than men (β=0.28, 95% CI 0.16 to 0.39) (all p≤0.05). 
The addition of history of DKA to the fully adjusted 
models in those with T1D resulted in the weakening of 
the association of female sex with better language perfor-
mance (β=0.09, 95% CI −0.008 to 0.18, p=0.07) but did 
not meaningfully change the other reported associations. 
Table 2 Sample characteristics stratified by diabetes status
T1D T2D No diabetes
Women Men Women Men Women Men
n (%) 385 (51) 373 (49) 118 (51) 114 (49) 127 (51) 120 (49)
Demographics     
  Age (years), mean (SD) 67.0 (6.2) 67.5 (6.4) 68.6 (7.0) 68.8 (7.1) 68.4 (6.8) 69.0 (7.2)
  Race/Ethnicity, n (%)     
   White 330 (86) 317 (85) 98 (83) 97 (85) 105 (83) 105 (88)
   Hispanic 19 (5) 9 (2) 19 (16) 15 (13) 21 (17) 14 (12)
   Asian 10 (3) 9 (2) 0 (0) 1 (1) 0 (0) 0 (0)
   African- American 10 (3) 11 (3) 0 (0) 0 (0) 0 (0) 0 (0)
   Other 16 (4) 27 (7) 1 (1) 1 (1) 1 (1) 1 (1)
  College degree, n (%) 228 (59) 245 (66) 67 (57) 72 (63) 71 (56) 72 (60)
  Annual household income (US$)     
   0–59 999 134 (35) 94 (25) 49 (42) 34 (30) 31 (24) 22 (18)
   60 000–99 000 115 (30) 104 (28) 36 (31) 36 (32) 41 (32) 32 (27)
   100 000–199 000 88 (23) 115 (31) 23 (19) 29 (25) 40 (31) 47 (39)
   >200 000 22 (6) 30 (8) 3 (3) 10 (9) 10 (8) 14 (12)
  Health literacy, n (%)     
   3rd grade or below 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0)
   4th–6th grade 1 (0) 3 (1) 1 (1) 1 (1) 0 (0) 1 (1)
   7th–8th grade 14 (4) 29 (8) 10 (8) 13 (11) 3 (2) 17 (14)
   High school 370 (96) 341 (91) 107 (91) 100 (88) 123 (97) 102 (85)
General health     
  Ever smoked >100 cigarettes, n (%) 157 (41) 159 (43) 57 (48) 62 (54) 48 (38) 55 (46)
  How often drink alcohol     
   Do not drink, n (%) 104 (27) 109 (30) 41 (35) 31 (27) 20 (16) 17 (14)
   At least monthly, n (%) 134 (35) 96 (26) 50 (42) 47 (41) 50 (39) 44 (37)
   At least weekly, n (%) 143 (37) 161 (44) 26 (22) 35 (31) 57 (45) 59 (49)
  PSQI, mean (SD) 8.6 (2.9) 7.7 (2.6) 8.6 (2.4) 7.9 (2.7) 8.1 (2.7) 6.9 (2.1)
  GDS, mean (SD) 2.3 (2.5) 1.9 (2.1) 2.6 (2.7) 2.0 (2.2) 1.2 (1.4) 1.2 (1.5)
Diabetes characteristics     
  Age at diabetes onset (years), mean (SD) 28.9 (16.4) 27.2 (13.7) 55.3 (11.2) 54.3 (13.4) N/A N/A
  Diabetes duration (years), mean (SD) 38.0 (16.0) 40.3 (13.9) 13.4 (9.9) 14.5 (12.6) N/A N/A
  Retinopathy, n (%) 175 (45) 145 (39) 7 (6) 12 (11) 1 (1) 1 (1)
  Neuropathy, n (%) 155 (40) 147 (39) 26 (22) 30 (26) 10 (8) 6 (5)
  Nephropathy, n (%) 28 (7) 31 (8) 0 (0) 1 (1) 1 (1) 0 (0)
  Stroke, n (%) 30 (8) 34 (9) 7 (6) 13 (11) 8 (6) 8 (7)
  Myocardial infarction, n (%) 44 (11) 50 (13) 6 (5) 16 (14) 4 (3) 6 (5)
  Severe hypoglycemia n (%) 178 (46) 191 (51) 5 (4) 2 (2) N/A N/A
  Diabetic ketoacidosis, n (%) 134 (35) 78 (21) 0 (0) 1 (1) N/A N/A
Bold signifies p values≤0.05.
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The further addition of history of severe hypoglycemia 
requiring hospitalization did not result in any further 
meaningful change in the reported associations. In those 
with T2D, women had better cognitive performance than 
men in global cognition (β=0.19, 95% CI 0.07 to 0.31) 
and episodic verbal memory (β=0.65, 95% CI 0.42 to 
0.87) (all p≤0.001) but not the other cognitive domains. 
The inclusion of history of DKA and/or severe hypogly-
cemia did not meaningfully change our results. In those 
without diabetes, female sex was associated with better 
global cognition (β=0.24, 95% CI 0.13 to 0.35), execu-
tive function (β=0.19, 95% CI 0.04 to 0.35) and episodic 
verbal memory (β=0.79, 95% CI 0.59 to 1.00) than men 
(all p<0.01). There were no associations between sex and 
language, episodic visual memory or attention factors 
among individuals without T1D or T2D. Figure 1 provides 
a visual representation of the associations between sex 
and predicted cognitive domain factor scores within 
diabetes status strata using the models described in 
table 3. The unadjusted mean cognitive factor scores by 
sex and diabetes status are presented in online supple-
mental table 2. The inclusion of measures of cardio-
vascular health and health literacy resulted in minimal 
attenuation of the associations between female sex and 
the cognitive outcomes (data not shown), with the only 
meaningful change being the previously described asso-
ciation between female sex and greater executive func-
tion in those without diabetes was no longer statistically 
significant (β=0.11, 95% CI −0.04 to 0.26).
DISCUSSION
In this sample of people without dementia, we found 
that women performed better than men globally and 
in many of the individual cognitive domains regardless 
of diabetes status. Furthermore, the amplitude of the 
sex differences appeared similar across diabetes states. 
To our knowledge, previous studies have not examined 
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Bold signifies p values≤0.05.
*Models adjusted for age, education, race, PSQI score and GDS score.
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for the presence of sex differences in cognitive func-
tion across T1D and T2D. These results suggest that the 
well- described better cognitive functioning of women 
compared with men without dementia is maintained in 
the presence of both T1D and T2D.
Previous work has reported that in people without 
diabetes, women have better cognitive functioning 
than men. Both the original analyses of the Health and 
Retirement Study21 and the follow- up of the same study 
performing a modified version of the Telephone Inter-
view for Cognitive Status on 18 982 people aged 51 years 
or older, reported that women had better global cognition 
and cognitive subdomains scores than men.22 A similar 
pattern was observed in a study of 2503 participants in the 
Framingham Heart Study where women (mean age >60 
years) had significantly higher performance on visual/
spatial memory, verbal memory and attention/concen-
tration than men.23 Reconciling this observation with the 
greater dementia risk in women has led others to suggest 
that better cognitive test performance of women may 
mask functional cognitive changes leading to delayed 
diagnosis and at more advanced stages.3
Fewer studies have examined the role of sex differences 
on cognitive outcomes in people with diabetes.8 24–30 
Research on cognitive outcomes in older people with 
T1D have started only recently, partly due to the rela-
tively recent ability of people with T1D to reach older 
ages. In those studies that have examined the associations 
between sex and cognition, specific sex difference data 
have not been presented.
Studies of sex differences in cognition in people with 
T2D have mostly focused on dementia as the outcome 
of interest. A 2016 meta- analysis of 2.3 million people 
reported that women with T2D had a greater risk of 
dementia than men with T2D.8 When examined by 
dementia subtype, women had a greater risk than men 
only for vascular dementia. The results from the Action for 
Health in Diabetes, a randomized controlled clinical trial 
of a 10- year intensive lifestyle intervention in people aged 
45–76 years with T2D reported that women (n=2323) had 
a 30% lower prevalence of mild cognitive impairment 
(MCI; a precursor to dementia) and better cognitive 
performance at study completion than men (n=1479).31 
The authors reported that these sex differences were 
not attributable to other risk factor profile characteris-
tics, T2D treatment or glycemic control differences. Our 
observation that between- sex differences in cognition was 
similar in all three groups and that the better cognitive 
performance in women was independent of occurrence 
of DKA lends credence to the argument that differences 
in glycemic control or diabetes treatments do not seem to 
explain the between- sex cognitive differences we report. 
More detailed work is required to better understand the 
role of more nuanced measures of glycemic control in sex 
differences and cognitive outcomes, which are lacking in 
our study.
Previous work has reported that men tend to perform 
better than women in visual memory tasks.12 However, in 
our sample, we found that men and women had similar 
visual memory ability. The implications of this are unclear. 
Further work, including the use of sensitive neuroim-
aging biomarkers of function and structure would help 
explore the significance of this finding.
The biological or mechanistic factors underlying the 
generally better cognitive function in women than men 
remain unclear. Sex hormones are known to be neuro-
protective in both sexes13 and the results of some studies 
suggest that women’s hormonal profile may explain some 
of the cognitive differences seen. Women with estrogen 
deficiency (induced either by surgical or hormone antag-
onism) show a reduction in verbal memory that is revers-
ible with estrogen treatment or resumption of normal 
ovarian function.14 15 However, it is unknown whether, 
or how, hormonal changes might be related to function 
in a particular cognitive domain. Work performed in the 
Alzheimer’s Disease Neuroimaging Dataset suggests that 
Figure 1 Associations between sex and predicted cognitive performance by diabetes status*. *Adjusted for age, race/
ethnicity, education, Pittsburg Sleep Quality Index score and Geriatric Depression Scale score. Models based on a white 
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these sex- cognitive domain differences are preserved even 
in the presence of disease, with women with amnestic MCI 
displaying better verbal memory than men with MCI.32 
Furthermore, the authors reported that these differences 
remained apparent even though hippocampal volume 
(important in verbal memory) was similar. These results 
suggest that there may be important between- sex differ-
ences in brain structure that might explain difference 
in cognitive function. Although no consistent patterns 
of sex- related brain structural differences have been 
found,33–46 differences in number and density of neurons 
as well as brain size may all be important in understanding 
sex- related patterns in specific cognitive domains as well 
as sex differences in future dementia risk.47 48
We found that the associations between sex and cogni-
tive function were independent of the known associ-
ations between diabetes and cognition. Similarly, the 
associations between diabetes and cognitive function 
did not vary by sex. Although our study suggests that 
the cognitive action of these two important risk factors 
are independent of each other, it is important to recog-
nize the possibility that factors associated with sex and 
diabetes may still interact in ways we did not detect. The 
pathways through which both diabetes and female sex 
lead to increased risk of dementia remain unknown. 
Additional research is needed to examine the protective 
role of female hormones on vascular risk factors and the 
implications of menopause on this loss of protection and 
long- term brain health.
This study has a number of strengths including the 
large sample size of people with T1D, inclusion of well- 
matched T2D and without diabetes samples, and the use 
of detailed comprehensive cognitive tests allowing for 
investigation of the effects of sex on specific cognitive 
domains. This study also has some limitations. We lacked 
comprehensive detail of other factors of interest such as 
severity of comorbidities, biomarkers of glucose control 
and anthropometry such as body mass index. On visual-
ization of the data, if any sex- diabetes class interactions 
are present, they appear to be very subtle and would 
require much larger sample sizes. Previous work in large 
meta- analyses has reported that in people with diabetes, 
women have a greater risk of stroke10 and coronary heart 
disease11 than men. We did not see this pattern in our 
cohort. It is likely that volunteer study participants are 
healthier than their non- volunteering counterparts. This 
is particularly the case when recruiting older people with 
T1D, who are likely to have had better glycemic control 
and fewer health complications throughout life than 
their counterparts who have since died, which may lead 
to survivor bias. We found a similar pattern within our 
sample, whereby those who completed all the cogni-
tive tests appeared healthier with greater education 
and annual household income that those who did not 
complete all cognitive tests. It is possible that the asso-
ciations we report would be different in those who had 
poorer glycemic control, greater burden of diabetes- 
related or non- diabetes- related comorbidities. The 
greater than expected age at diagnosis of those with T1D 
might be reflective of the biases of healthier people to 
enroll in studies or be the result of survivor- bias, whereby 
those with earlier age of diagnosis may not have survived 
to the age to be eligible to be included in our study. It is 
also possible that cognitive changes in our cohort were 
too subtle to detect with our neuropsychological tests. 
Future plans include obtaining objective measures of 
health from the medical record and following enrolled 
participants longitudinally for cognitive change. As we 
currently present cross- sectional analyses, it is important 
to understand whether these patterns continue over time 
or whether there are between- sex differences in cognitive 
trajectories.
In summary, women in mid- later life have better cogni-
tive performance than men in many cognitive domains 
and this is independent of the presence of T1D or T2D. 
Further work is required to understand whether these 
differences change over time and their relationship to 
subsequent dementia.
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Supplementary Figure 1. Flow chart of study recruitment and enrolment 
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Supplementary Table 1. Sample characteristics of those who completed and did not 
complete all cognitive tests.  
 Whole group Missing global 
cognition 
n (%) 1237 70 
Demographics   
Age (years) Mean (SD) 67.8 (6.6) 70.4 (7.2) 
Race/ethnicity, n (%)   
White 1052 (85) 60 (85) 
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Hispanic 97 (8) 5 (7) 
Asian 20 (2) 1 (1) 
African American 21 (2) 1 (1) 
Other 47 (4) 3 (4) 
College degree, n (%) 755 (61) 37 (53%) 
Annual household income    
$USD 0-59,999 364 (29) 31 (44) 
 $USD 60,000-99,000 364 (29) 8 (11) 
$USD 100,000-199,000  342 (28) 19 (27) 
>$USD 200,000 89 (7) 3 (4) 
General health   
Every smoked> 100 cigarettes, n (%) 538 (43) 32 (46) 
How often drink alcohol    
Don’t drink, n (%) 322 (26) 25 (36) 
At least monthly, n (%) 421 (34) 21 (30) 
At least weekly, n (%) 481 (39) 21 (30) 
PSQI, Mean (SD) 8.0 (2.7) 8.6 (3.2) 
GDS, Mean (SD) 2.0 (2.3) 3.5 (3.7) 
Subjective memory loss, n (%) 720 (58) 41 (59) 
No Diabetes, n (%) 247 (20) 11 (16) 
Type 1 Diabetes, n (%) 758 (61) 43 (61) 
Type 2 Diabetes, n (%) 232 (19) 16 (23) 
Diabetes characteristics    
Mean age at diabetes onset (years)(SD) 34.4 (18.4) 30.9 (16.8) 
Mean diabetes duration (years) (SD) 33.1 (17.8) 38.8 (16.7) 
Retinopathy, n (%) 341 (28) 23 (33) 
Neuropathy, n (%) 374 (30) 30 (43) 
Nephropathy, n (%) 61 (5) 7 (10) 
Stroke, n (%) 100 (8) 11 (16) 
Myocardial infarction, n (%) 126 (10) 10 (14) 
Severe hypoglycemia n (%) 376 (30) 26 (37) 
Diabetic ketoacidosis, n (%) 213 (17) 16 (23) 
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Supplementary Table 2. Raw mean cognitive function factor scores by sex and diabetes 
status 
  Women 
Factor Score 




Type 1 diabetes, n (%) n 409 (51) 396 (49) 
Global score 758 0.14 (0.51) -0.09 (0.50) 
Language 743 0.04 (0.69) -0.02 (0.67) 
Executive 745 0.05 (0.77) -0.09 (0.76) 
Verbal episodic memory  0.33 (0.84) -0.36 (0.90) 
Visual episodic memory 370 0.14 (0.77) 0.13 (0.76) 
Attention 377 0.16 (0.64) -0.11 (0.82) 
Type 2 diabetes, n (%)  125 (50.4) 123 (49.6) 
Global score 118 0.06 (0.48) -0.07 (0.50) 
Language 117 0.08 (0.73) 0.02 (0.67) 
Executive 117 0.13 (0.70) 0.07 (0.63) 
Verbal episodic memory 110 0.37 (0.81) -0.15 (0.87) 
Visual episodic memory 116 -0.26 (0.60) -0.22 (0.64) 
Attention 117 0.0002 (0.78) -0.07 (0.84) 
No Diabetes, n (%)  127 120 
Global score 247 0.22 (0.53) -0.005 (0.52) 
Language 244 0.22 (0.73) 0.11 (0.68) 
Executive 246 0.35 (0.75) 0.19 (0.68) 
Verbal episodic memory 237 0.48 (0.78) -0.31 (0.89) 
Visual episodic memory 242 -0.02 (0.72) -0.05 (0.80) 
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